Banque Cantonale Vaudoise increased its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 11.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,251 shares of the health services provider’s stock after purchasing an additional 1,984 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Cigna Group were worth $5,136,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently bought and sold shares of CI. Brighton Jones LLC increased its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. Sivia Capital Partners LLC boosted its position in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after purchasing an additional 109 shares during the period. NewEdge Advisors LLC increased its holdings in Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after purchasing an additional 958 shares in the last quarter. Treasurer of the State of North Carolina increased its holdings in Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after purchasing an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new position in Cigna Group in the second quarter valued at about $163,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Insider Buying and Selling
In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the firm earned $6.74 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.
Analyst Upgrades and Downgrades
A number of research analysts have commented on CI shares. Morgan Stanley boosted their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Jefferies Financial Group dropped their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Piper Sandler reduced their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. Sanford C. Bernstein upped their price target on Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Finally, Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $338.30.
Check Out Our Latest Stock Report on Cigna Group
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
